Showing results (91-100 of 2,881) with videos related to
Sort By:
Pageof 289
Expert Opinion on Investigational Drugs|June 24, 2004
Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utilityAnirban Choudhury, Gregory Y H LipSeminars in Vascular Medicine|August 27, 2005
Ximelagatran in the clinic: practical management of patientsSam Schulman, Gregory Y H LipEuropean Heart Journal|May 10, 2014
Edoxaban: a focused review of its clinical pharmacologyGregory Y H Lip, Giancarlo AgnelliThrombosis and Haemostasis|February 19, 2008
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness dataMichael Hughes, Gregory Y H Lip, Current Treatment Options in Neurology|February 11, 2015
Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial FibrillationQinmei Xiong, Gregory Y H LipCurrent Cardiology Reviews|August 28, 2012
Stroke prevention in atrial fibrillation: concepts and controversiesYousif Ahmad, Gregory Y H LipAnnals of Internal Medicine|May 1, 2023
In limb or pelvic fracture, aspirin was noninferior to enoxaparin for reducing all-cause deathMichael Griffin, Gregory Y H LipAnnals of Internal Medicine|August 4, 2025
In uncontrolled hypertension, adding lorundrostat to a standardized AHT regimen reduced SBP at 12 wkAlena Shantsila, Gregory Y H Lip, Annals of Internal Medicine|March 31, 2025
In HF with mildly reduced or preserved ejection fraction, finerenone reduced CV death and worsening HF, regardless of baseline LVEFYang Wang, Gregory Y H Lip, The American Journal of Medicine|July 27, 2010
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?Gregory Y H Lip, Deirdre A LanePageof 289